Abstract
Multi drug resistance (MDR) or cross resistance to drugs was initially explained on the basis that MDR cells express drug transporters that expel membrane-embedded drugs. However, it is now clear that transporters are a single piece from a complex puzzle. An issue that has been solved recently is, given that these transporters have to handle drugs, why should a membrane-embedded drug and a transporter meet? To solve this problem, a theory has been suggested considering the interaction between the cell membrane mechanical properties and the size of drugs. In simple terms, this theory proposes that an excess in the packing of lipid in the inner leaflet of the membrane of MDR cells is responsible for blocking drugs mechanically as a function of their sizes at the membrane level, thus impairing their flux into the cytosol. In turn it is expected that this would allow any membrane embedded drug to diffuse toward transporters. The study concluded that the size of drugs is necessarily important regarding the mechanical interaction between the drug and the membrane, and likely to be central to MDR. Remarkably, an experimental study based on MDR and published years ago concluded that the molecular weight (MW) of drugs was central to MDR (Biedler and Riehm in Cancer Res 30:1174–1184, 1970). Given that size and MW are linked together, I have compared the former theory to the latter experimental data and demonstrate that, indeed, basic membrane mechanics is involved in high levels of cross resistance to drugs in Pgp expressing cells.
Notes
The mean mechanical membrane tension corresponds to the mean lipid packing of the membrane leaflets.
A point that certainly needs clarification is related to the affinity between drugs and transporters. It is well known that the binding affinity between drugs and transporters varies between drugs, and it could be postulated that drug with a low MW may have a lower binding affinity with transporters. In turn this could explain why drugs with a low MW cross the membrane more easily as they are not (or less) extruded by transporters (see Fig. 1a). Given that the term “affinity” defined in physics suggests a favorable interaction, if the MW of drugs was to be involved this would mean that the mass of the drug should be responsible for this affinity. The only force that exists and involves the mass as a source of interaction is the gravity. However, application of the gravitational law is only valid over very large scales, well beyond the molecular scale. Thus, the gravity can not be applied in our case. In turn, this means that the assumption suggesting that the binding affinity between drugs and transporters is related to the MW of drugs can be ruled out.
Mechanically, less energy is required to bend a flat object to give this object a small curvature (i.e. large radius: curvature = 1/radius) than to give it a high curvature.
References
Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson JD (1994) Biologie Moleculaire de La Cellule, New York
Altan N, Chen Y, Schindler M, Simon SM (1998) Defective acidification in human breast tumor cells and implications for chemotherapy. J Exp Med 187:1583–1598. doi:10.1084/jem.187.10.1583
Altan N, Chen Y, Schindler M, Simon SM (1999) Tamoxifen inhibits acidification in cells independent of the estrogen receptor. Proc Natl Acad Sci USA 96:4432–4437. doi:10.1073/pnas.96.8.4432
Bakovic M, Fullerton MD, Michel V (2007) Metabolic and molecular aspects of ethanolamine phospholipid biosynthesis: the role of CTP:phosphoethanolamine cytidylyltransferase (Pcyt2). Biochem Cell Biol 85:283–300. doi:10.1139/O07-006
Bemporad D, Luttmann C, Essex JW (2004) Computer simulation of small molecule permeation across a lipid bilayer: dependence on bilayer properties and solute volume, size, and cross-sectional area. Biophys J 87:1–13. doi:10.1529/biophysj.103.030601
Biedler JL, Riehm H (1970) Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic, and cytogenetic studies. Cancer Res 30:1174–1184
Brinkmann U, Eichelbaum M (2001) Polymorphisms in the ABC drug transporter gene MDR1. Pharmacogenomics J 1:59–64
Colin M, Madoulet C, Warren L, Jardillier JC (1996) Alterations of vinblastine influx in multidrug-resistant lymphoblastic leukaemic CEM cells. Anticancer Res 16:407–412
Cribier S, Sainte-Marie J, Devaux PF (1993) Quantitative comparison between aminophospholipid translocase activity in human erythrocytes and in K562 cells. Biochim Biophys Acta 1148:85–90. doi:10.1016/0005-2736(93)90163-T
Devaux PF (2000) Is lipid translocation involved during endo- and exocytosis? Biochimie 82:497–509. doi:10.1016/S0300-9084(00)00209-1
Devaux PF, Zachowski A, Morrot G, Cribier S, Fellmann P, Geldwerth D, Bitbol M, Herve P (1990) Control of the transmembrane phospholipid distribution in eukaryotic cells by aminophospholipid translocase. Biotechnol Appl Biochem 12:517–522
Farge E, Devaux PF (1992) Shape changes of giant liposomes induced by an asymmetric transmembrane distribution of phospholipids. Biophys J 61:347–357
Farge E, Ojcius DM, Subtil A, Dautry-Varsat A (1999) Enhancement of endocytosis due to aminophospholipid transport across the plasma membrane of living cells. Am J Physiol 276:C725–C733
Ferte J (2000) Analysis of the tangled relationships between P-glycoprotein-mediated multidrug resistance and the lipid phase of the cell membrane. Eur J Biochem 267:277–294. doi:10.1046/j.1432-1327.2000.01046.x
Hendrich AB, Michalak K (2003) Lipids as a target for drugs modulating multidrug resistance of cancer cells. Curr Drug Targets 4:23–30. doi:10.2174/1389450033347172
Hochmuth FM, Shao JY, Dai J, Sheetz MP (1996) Deformation and flow of membrane into tethers extracted from neuronal growth cones. Biophys J 70:358–369
Itoh T, De Camilli P (2006) BAR, F-BAR (EFC) and ENTH/ANTH domains in the regulation of membrane-cytosol interfaces and membrane curvature. Biochim Biophys Acta 1761:897–912
Karshikoff A (2006) Non-covalent interactions in proteins, 2006 edn. Imperial College Press, London
Kiss Z, Crilly KS (1995) Tamoxifen inhibits uptake and metabolism of ethanolamine and choline in multidrug-resistant, but not in drug-sensitive, MCF-7 human breast carcinoma cells. FEBS Lett 360:165–168. doi:10.1016/0014-5793(95)00094-P
Liang X, Huang Y (2002) Physical state changes of membrane lipids in human lung adenocarcinoma A(549) cells and their resistance to cisplatin. Int J Biochem Cell Biol 34:1248–1255. doi:10.1016/S1357-2725(02)00056-0
Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46:3–26. doi:10.1016/S0169-409X(00)00129-0
Marathe PH, Rodrigues AD (2006) In vivo animal models for investigating potential CYP3A- and Pgp-mediated drug–drug interactions. Curr Drug Metab 7:687–704. doi:10.2174/138920006778520598
Miao L, Seifert U, Wortis M, Dobereiner HG (1994) Budding transitions of fluid-bilayer vesicles: the effect of area-difference elasticity. Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics 49:5389–5407. doi:10.1103/PhysRevE.49.5389
Mitragotri S, Johnson ME, Blankschtein D, Langer R (1999) An analysis of the size selectivity of solute partitioning, diffusion, and permeation across lipid bilayers. Biophys J 77:1268–1283
Nossal R, Zimmerberg J (2002) Endocytosis: curvature to the ENTH degree. Curr Biol 12:R770–R772. doi:10.1016/S0960-9822(02)01289-7
Petelska AD, Figaszewski ZA (2002) Effect of pH on the interfacial tension of bilayer lipid membrane formed from phosphatidylcholine or phosphatidylserine. Biochim Biophys Acta 1561:135–146. doi:10.1016/S0005-2736(01)00463-1
Petrache HI, Zemb T, Belloni L, Parsegian VA (2006) Salt screening and specific ion adsorption determine neutral-lipid membrane interactions. Proc Natl Acad Sci USA 103:7982–7987. doi:10.1073/pnas.0509967103
Pomorski T, Menon AK (2006) Lipid flippases and their biological functions. Cell Mol Life Sci 63:2908–2921. doi:10.1007/s00018-006-6167-7
Raghunand N, Martinez-Zaguilan R, Wright SH, Gillies RJ (1999) pH and drug resistance. II. Turnover of acidic vesicles and resistance to weakly basic chemotherapeutic drugs. Biochem Pharmacol 57:1047–1058. doi:10.1016/S0006-2952(99)00021-0
Rauch C, Farge E (2000) Endocytosis switch controlled by transmembrane osmotic pressure and phospholipid number asymmetry. Biophys J 78:3036–3047
Rauch C, Pluen A (2007) Multi drug resistance-dependent “vacuum cleaner” functionality potentially driven by the interactions between endocytosis, drug size and Pgp-like transporters surface density. Eur Biophys J 36:121–131. doi:10.1007/s00249-006-0113-3
Safa AR, Glover CJ, Meyers MB, Biedler JL, Felsted RL (1986) Vinblastine photoaffinity labeling of a high molecular weight surface membrane glycoprotein specific for multidrug-resistant cells. J Biol Chem 261:6137–6140
Schindler M, Grabski S, Hoff E, Simon SM (1996) Defective pH regulation of acidic compartments in human breast cancer cells (MCF-7) is normalized in adriamycin-resistant cells (MCF-7adr). Biochemistry 35:2811–2817. doi:10.1021/bi952234e
Seigneuret M, Devaux PF (1984) ATP-dependent asymmetric distribution of spin-labeled phospholipids in the erythrocyte membrane: relation to shape changes. Proc Natl Acad Sci USA 81:3751–3755. doi:10.1073/pnas.81.12.3751
Selassie CD, Hansch C, Khwaja TA (1990) Structure–activity relationships of antineoplastic agents in multidrug resistance. J Med Chem 33:1914–1919. doi:10.1021/jm00169a014
Venkatesan PV, Saravanan K, Nagarajan B (1998) Characterization of multidrug resistance and monitoring of tumor response by combined 31P and 1H nuclear magnetic resonance spectroscopic analysis. Anticancer Drugs 9:449–456. doi:10.1097/00001813-199806000-00012
Victorov AV, Janes N, Taraschi TF, Hoek JB (1997) Packing constraints and electrostatic surface potentials determine transmembrane asymmetry of phosphatidylethanol. Biophys J 72:2588–2598
Walter A, Gutknecht J (1986) Permeability of small nonelectrolytes through lipid bilayer membranes. J Membr Biol 90:207–217. doi:10.1007/BF01870127
Xiang TX, Anderson BD (1994) The relationship between permeant size and permeability in lipid bilayer membranes. J Membr Biol 140:111–122. doi:10.1007/BF00232899
Zamora JM, Pearce HL, Beck WT (1988) Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells. Mol Pharmacol 33:454–462
Zhang Y, Benet LZ (2001) The gut as a barrier to drug absorption: combined role of cytochrome P450 3A and P-glycoprotein. Clin Pharmacokinet 40:159–168. doi:10.2165/00003088-200140030-00002
Acknowledgments
I thank Prof. Paul Roepe for telling me that he and his lab found that the MW of chemicals are determinant to cross bilayer membranes. This remark has encouraged a bibliographic research and the present communication. I am in dept to Aurelien Madouasse and Dr Nigel Kendal who, patiently, explained me the importance of statistic rules and tests. This work has been supported by the Medical Research Council (RA3805) and the University of Nottingham (NRF4305).
Author information
Authors and Affiliations
Corresponding author
Appendix
Appendix
Assuming a flat membrane composed of two leaflets and containing, N in lipids in the inner leaflet and, N out lipids in the outer leaflet (N in > N out). The relative lipid number asymmetry: ΔN/N 0, with ΔN = (N in − N out) and N 0 = (N in + N out)/2, generates a differential packing across the membrane of thickness, h. In turn this generates a momentum (i.e. a bending force): ∼ h K ΔN/N 0, that is proportional to the elastic modulus of leaflets, K, and that tends to bend the membrane inwardly (Fig. 1c).
However, the bending stiffness of the membrane, i.e. the membrane bending modulus k c, balances the inward bending by an outward bending force that is proportional to k c and inversely proportional to the radius, R, of the vesicle to be created: ∼ k c/R. As such the bending stiffness of the membrane imposes a limit to the creation of too small vesicles.Footnote 3 Finally, given this mechanical model of membrane budding, the optimal size of vesicles is dictated by the equilibrium between the inward and outward bending forces, namely: h KΔN/N 0 ∼ k c /R ⇒ R ∼ k c /(hKΔN/N 0). A detailed analysis gives R = 8k c/hK(ΔN/N 0)(Rauch and Farge 2000).
Rights and permissions
About this article
Cite this article
Rauch, C. On the relationship between drug’s size, cell membrane mechanical properties and high levels of multi drug resistance: a comparison to published data. Eur Biophys J 38, 537–546 (2009). https://doi.org/10.1007/s00249-008-0385-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00249-008-0385-x